Evidence map›Paper›PMID 38139248›Full record

ReviewInternational journal of molecular sciences2023

Radiotracers for Imaging of Inflammatory Biomarkers TSPO and COX-2 in the Brain and in the Periphery.

Bright Chukwunwike Uzuegbunam, Christoph Rummel, Damiano Librizzi, Carsten Culmsee, Behrooz Hooshyar Yousefi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Comparison of [Molecular imaging and biology · 2026
    Article
  5. Article
  6. Article
  7. Current Uses for Medical Imaging With Orthopaedic Implant Technology.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026
    Review
  8. Article
  9. Observational
  10. Review
  11. RadiolabeledFrontiers in nuclear medicine · 2025
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Bright Chukwunwike UzuegbunamNuclear Medicine Department, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
Christoph RummelInstitute of Veterinary Physiology and Biochemistry, Justus Liebig University Giessen, 35392 Gießen, Germany.ORCID 0000-0001-5457-4390
Damiano LibrizziDepartment of Nuclear Medicine, Philipps University of Marburg, 35043 Marburg, Germany.
Carsten CulmseeCenter for Mind Brain and Behavior, Universities Giessen and Marburg, 35043 Marburg, Germany.ORCID 0000-0002-5121-5015
Behrooz Hooshyar YousefiDepartment of Nuclear Medicine, Philipps University of Marburg, 35043 Marburg, Germany.ORCID 0000-0003-0679-4449
Philipps University of Marburg · DEJustus-Liebig-Universität Gießen · DETUM Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation involves the activation of innate immune cells and is believed to play an important role in the development and progression of both infectious and non-infectious diseases such as neurodegeneration, autoimmune diseases, pulmonary and cancer. Inflammation in the brain is marked by the upregulation of translocator protein (TSPO) in microglia. High TSPO levels are also found, for example, in macrophages in cases of rheumatoid arthritis and in malignant tumor cells compared to their relatively low physiological expression. The same applies for cyclooxgenase-2 (COX-2), which is constitutively expressed in the kidney, brain, thymus and gastrointestinal tract, but induced in microglia, macrophages and synoviocytes during inflammation. This puts TSPO and COX-2 in the spotlight as important targets for the diagnosis of inflammation. Imaging modalities, such as positron emission tomography and single-photon emission tomography, can be used to localize inflammatory processes and to track their progression over time. They could also enable the monitoring of the efficacy of therapy and predict its outcome. This review focuses on the current development of PET and SPECT tracers, not only for the detection of neuroinflammation, but also for emerging diagnostic measures in infectious and other non-infectious diseases such as rheumatic arthritis, cancer, cardiac inflammation and in lung diseases.

Indexed as

Arthritis, RheumatoidNoncommunicable DiseasesBiomarkersBrainCarrier ProteinsCyclooxygenase 2HumansInflammationPositron-Emission TomographyReceptors, GABABiomarkersCarrier ProteinsCyclooxygenase 2Receptors, GABATSPO protein, humancyclooxygenase-2 (COX-2)myocarditisneuroinflammationpneumoniapositron emission tomography (PET)single-photon emission tomography (SPECT)tracer developmenttranslocator protein (TSPO)

Identifiers

PMID38139248
PMCPMC10743508
OpenAlexW4389680341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.